<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">

NEWSROOM Press Releases

    254 Results

    Biodesix Closes Series D Financing - August 2012

    Biodesix has closed on a $12 million extension to its Series D financing. The new capital will support commercialization activities for VeriStrat.

    Biodesix Advances the Field of Personalized Medicine with the Launch of VeriStrat®

    Biodesix announces the U.S. commercial availability of VeriStrat.

    Biodesix’ Paul Beresford Joins 2012 BIO Panel for Personalized Medicine Commercialization

    Biodesix’ Paul Beresford will join industry veterans on a panel discussing the recipe for the successful commercialization of personalized medicine.

    Biodesix Receives 2011 North American Cancer Diagnostics Product Differentiation Excellence Award

    Biodesix received the Product Differentiation Excellence Award for its accomplishments in the cancer diagnostics industry.

    Biodesix to Present at 2011 Biotech Showcase

    Biodesix's Paul Beresford will present at the 2011 Biotech Showcase conference taking place January 10–12th at the Parc 55 Wyndham in San Francisco, CA

    Biodesix Supports Unique Lung Cancer Research Initiative – CASTLE study enrolls initial subjects

    Biodesix announces the enrollment of initial subjects into CASTLE, the inaugural study of the Addario Lung Cancer Medical Institute.

    Biodesix Issued Four Additional U.S. Patents for Blood-based Oncology Tests

    Biodesix announced that the U.S. Patent & Trademark Office has issued four patents for the protection of the company's products and technology.